Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00431015
Status:
COMPLETED
Last Update Posted:
2012-12-10
First Post:
2007-01-31
Brief Title:
Phase III Safety Study of IPI-504 in RelapsedRefractory Stage IIIb or Stage IV Non-small Cell Lung Cancer NSCLC
Sponsor:
Organization:
Infinity Pharmaceuticals Inc